Omada Health (OMDA) Cash Flow Statement

The gap between net income and operating cash flow in Q2 2026 is modest but notable, with a negative working capital change of -$10.3M absorbing cash. This pattern suggests that reported profitability may not fully translate into cash generation, as receivables or other current assets consume cash. Investors should monitor whether this working capital drag persists as revenue scales, as it could indicate collection inefficiencies or aggressive revenue recognition.

The trajectory shows a clear improvement from deep negative FCF in early 2025 to positive territory in recent quarters, driven by revenue growth and cost discipline. However, the FCF margin of 6.1% remains thin relative to peers like Teladoc's 9.0%, suggesting limited cushion if growth decelerates. The positive FCF in Q2 2026 is a critical milestone, but its durability depends on maintaining revenue momentum and controlling working capital.

Omada's capex intensity is exceptionally low, consistent with a digital platform business, but the slight uptick in Q2 2026 (1.5% of revenue) may indicate investment in infrastructure or product development. This low capex requirement means that operating cash flow can largely convert to FCF, but it also implies that growth is not capital-intensive, which could support future profitability. The minimal capex suggests that any cash burn is driven by operating costs, not asset expansion.

The working capital line is the primary driver of operating cash flow variability, as evidenced by the large negative changes in Q1 2026 and Q2 2026. This suggests that Omada's cash conversion is sensitive to the timing of collections and payments, possibly due to performance-based contracts and enrollment cycles. Investors should expect lumpy cash flows and focus on annual trends rather than quarterly noise, as the company scales its enterprise contracts.

The absence of capital returns indicates a reinvestment phase, with management prioritizing growth over shareholder distributions. The $222M cash pile provides a buffer for operational needs and strategic initiatives, but investors should monitor whether it is deployed efficiently. Given the company's near-breakeven status, the cash may be used to weather potential volatility or to acquire complementary capabilities, though no acquisitions were reported in the data.

The cumulative divergence between net income and operating cash flow suggests that non-cash charges, such as stock-based compensation and depreciation, have cushioned the cash impact of losses. This implies that the company's cash runway is longer than net income alone would suggest, but it also highlights the dilutive effect of SBC. As Omada approaches profitability, the gap should narrow, but the quality of earnings will depend on whether cash conversion improves.